Ionic Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,530
Closed -$271K 472
2021
Q4
$271K Buy
+3,530
New +$281K 0.03% 265
2018
Q2
Sell
-12,576
Closed -$654K 254
2018
Q1
$654K Sell
12,576
-171,977
-93% -$9.29M 0.04% 189
2017
Q4
$9.91M Buy
184,553
+126,832
+220% +$7.03M 0.41% 52
2017
Q3
$3.53M Buy
57,721
+29,870
+107% +$1.81M 0.14% 142
2017
Q2
$1.7M Buy
27,851
+17,058
+158% +$1.04M 0.09% 181
2017
Q1
$654K Buy
+10,793
New +$655K 0.04% 238

Other funds holding MRK

Ionic Capital Management's MRK Position: Q1 2022 in Review

Ionic Capital Management sold out of Merck (MRK) in Q1 2022, closing a stake of 3,530 shares — an estimated $271K sold.

Ionic Capital Management first reported a position in MRK in Q1 2017 and held it in 6 quarters. The position peaked at $9.91M in Q4 2017. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Ionic Capital Management reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Ionic Capital Management sold 3,530 Merck shares in Q1 2022, an estimated $271K.
  • Ionic Capital Management first reported a position in Merck in Q1 2017 and held it in 6 quarters.
  • Ionic Capital Management's Merck position peaked at $9.91M in Q4 2017.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Ionic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.